Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Granada – page 33

395 clinical trials in Granada, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Granada at a glance
395
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

395 trials in Granada

Open in trial search

Partial seizures

Not recruiting

Study on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:PRAX-628
  • Sponsor:Praxis Precision Medicines Inc.

Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan
  • Sponsor:Medica Scientia Innovation Research S.L.

HIV infection

Not recruiting

Study on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Abacavir Sulfate
  • Sponsor:Stichting Radboud universitair medisch centrum

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Pfizer Inc.

Plasma cell myeloma

Not recruiting

Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Bortezomib
  • Sponsor:Fundacion PETHEMA

Plasma cell myeloma

Not recruiting

Study on Carfilzomib, Lenalidomide, and Dexamethasone for Patients Under 70 with High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Fundacion PETHEMA

Pemphigoid

Not recruiting

Study on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Liver transplant+1

Not recruiting

Study on Liver Transplantation: Comparing Custodiol-N Solution with a Drug Combination for Organ Preservation in Patients Undergoing Liver Transplant Surgery

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Alanine
  • Sponsor:Dr. Franz Koehler Chemie GmbH

Breast cancer metastatic+1

Not recruiting

Study of Alpelisib, Trastuzumab, and Fulvestrant for Patients with PIK3CA Mutated HER2+ Advanced Breast Cancer Previously Treated with Trastuzumab

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Cardiac failure+4

Not recruiting

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:CDR132L
  • Sponsor:Cardior Pharmaceuticals GmbH

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum der Universitaet Muenchen AöR

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Granada

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on multiple cancer types including colorectal cancer, breast cancer, and glioblastoma. Studies are evaluating novel treatment approaches and combination therapies.

  • Metastatic colorectal cancer treatment optimization
  • Triple-negative breast cancer therapies
  • Prostate cancer diagnostics and treatment

Advanced imaging techniques and targeted therapies are being investigated to improve patient outcomes.

02 Respiratory Medicine

Research targeting respiratory conditions with a focus on chronic obstructive pulmonary disease. Studies are examining new therapeutic approaches for moderate to severe cases.

  • COPD exacerbation management
  • Novel therapeutic antibodies
  • Bronchial disease treatments

Emphasis on reducing disease progression and improving quality of life for patients.

03 Dermatology Studies

Clinical investigations in various skin conditions including plaque psoriasis and atopic dermatitis. Research focuses on innovative biological treatments.

  • Moderate to severe psoriasis therapies
  • Hidradenitis suppurativa treatments
  • Novel dermatological interventions

Trials aim to develop more effective treatments for chronic skin conditions.

04 Neurological Research

Studies investigating treatments for Alzheimer's disease in specific populations, particularly focusing on prevention and management of associated conditions.

  • Alzheimer's disease in Down syndrome
  • Seizure prevention strategies
  • Neurological disorder management

Research aims to improve quality of life for patients with complex neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.